David Shaw’s Ambrx Biopharma Inc AMAM Stock Holding History

David Shaw’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,240,486	Closed	-$60.4M	–	4881
2023 Q4	$60.4M	Buy	4,240,486 +235,973	+6%	+$2.68M	0.05%	413
2023 Q3	$46.1M	Sell	4,004,513 -11,395	-0.3%	-$155K	0.05%	459
2023 Q2	$66.1M	Buy	4,015,908 +82,356	+2%	+$1.04M	0.07%	347
2023 Q1	$35.1M	Buy	+3,933,552	New	+$19.8M	0.04%	585

David Shaw's AMAM Position: Q1 2024 in Review

David Shaw sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 4,240,486 shares — an estimated $60.4M sold.

David Shaw first reported a position in AMAM in Q1 2023 and held it in 4 quarters. The position peaked at $66.1M in Q2 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

David Shaw reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
David Shaw sold 4,240,486 Ambrx Biopharma Inc shares in Q1 2024, an estimated $60.4M.
David Shaw first reported a position in Ambrx Biopharma Inc in Q1 2023 and held it in 4 quarters.
David Shaw's Ambrx Biopharma Inc position peaked at $66.1M in Q2 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.